Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127129061	12712906	1	I	20160824	20160825	20160902	20160902	PER		US-SHIRE-US201611590	SHIRE		49.00	YR		F	Y	0.00000		20160902		CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	RECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM
127129061	12712906	1	PS	VYVANSE	LISDEXAMFETAMINE DIMESYLATE	1	Oral	40 MG, UNKNOWN	U	21977	40	MG	CAPSULE
127129061	12712906	2	SS	VYVANSE	LISDEXAMFETAMINE DIMESYLATE	1	Oral	30 MG, UNKNOWN	U	21977	30	MG	CAPSULE
127129061	12712906	3	SS	VYVANSE	LISDEXAMFETAMINE DIMESYLATE	1	Oral	20 MG, UNKNOWN	U	21977	20	MG	CAPSULE
127129061	12712906	4	SS	VYVANSE	LISDEXAMFETAMINE DIMESYLATE	1	Oral	30 MG, UNKNOWN	U	21977	30	MG	CAPSULE

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127129061	12712906	1	Attention deficit/hyperactivity disorder

Outcome of event

Event ID	CASEID	OUTC COD
127129061	12712906	HO

Reactions reported

Event ID	CASEID	DRUG REC ACT	PT
127129061	12712906		Adverse event
127129061	12712906		Blood pressure increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
127129061	12712906	2		20160824	0